Institutional, Confidence

Institutional Confidence Grows in Synopsys as Major Investor Expands Stake

31.12.2025 - 11:41:04

Synopsys US8716071076

A significant institutional investor has made a substantial move in Synopsys shares just before the year's end. Calamos Advisors increased its stake in the semiconductor design software company by more than half, bringing the total value of its holdings to approximately $42.8 million. This vote of confidence coincides with the passing of a key deadline in a prolonged legal matter that had weighed on the stock.

Regulatory filings reveal that Calamos Advisors purchased an additional 30,516 shares on December 31, 2025. This acquisition represents a 54.3% increase in its position, raising its total holdings to 86,730 shares. Such a sizable investment by a professional fund manager is widely interpreted as a signal that recent share price weakness is viewed as a buying opportunity. It underscores a broader trend, as institutional investors now control 85.47% of Synopsys's outstanding shares, highlighting the substantial weight given to the company by major capital allocators.

Legal Overhang Potentially Diminishing

In a related development, the deadline for appointing a lead plaintiff in a securities class action lawsuit against Synopsys passed recently. The litigation was initiated following a sharp decline in the company's share price in September 2025, when the stock fell nearly 36% after disappointing financial results from its Design IP segment. The expiration of this deadline may remove a layer of legal uncertainty that has been a persistent overhang on the equity, potentially allowing investors to reassess the risk profile and paving the way for a valuation re-rating.

Should investors sell immediately? Or is it worth buying Synopsys?

Strong Operational Performance Provides Foundation

The company's underlying business performance remains robust, offering a solid foundation for investor optimism. Synopsys reported fourth-quarter revenue of $2.26 billion, exceeding its own guidance. For the full 2025 fiscal year, the company achieved a record $7.05 billion in revenue, marking a 15% year-over-year increase. A primary driver of this growth has been the successful integration of Ansys, which contributed approximately $757 million to the annual revenue. This strategic acquisition has significantly broadened Synopsys's business model and opened new avenues for expansion.

Market Analysts See Substantial Upside

The consensus among market analysts points to considerable upside potential. The average price target for Synopsys shares stands at $562, which is roughly 18% above the recent trading level near $474. This significant gap suggests that financial experts view the recent sell-off as overdone and anticipate a meaningful recovery in the stock's valuation.

Ad

Synopsys Stock: Buy or Sell?! New Synopsys Analysis from December 31 delivers the answer:

The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 31.

Synopsys: Buy or sell? Read more here...

@ boerse-global.de | US8716071076 INSTITUTIONAL